Background Thalassemia is a chronic disease that is becoming a major health problem in the world, including the Mediterranean, as well as Malaysia, Thailand and Indonesia. This condition clearly the effects of treatment. Assessment is needed to determine actions to be taken to improve the quality of life in thalassemic children.
Thalassemia has a negative impact on quality of life due to the effects of the disease and its treatment, their social, emotional, and school function, leading to an impaired quality of life. The most commonly affected domains previously reported were feelings of depression, anxiety, psychological problems, emotional burden, hopelessness, difficulty with social integration, and school problems. affected their family members, such as sadness, disappointment, hopelessness, stress, depression, and 13 The assessment of quality of life in thalassemic children and their family members is important in order to determine actions to be taken to improve quality of life. The aim of this study was to assess differences in quality of life of thalassemic children compared to their normal siblings.
Methods
We conducted a cross-sectional study from Mayclassifications and their normal siblings, with age at consent, and filled questionnaires completely. We excluded children with cognitive function problems, psychotic problems and cancer. thalassemic group and their normal siblings group. We measured anthropometric values of each child before the study began. Weight was measured with Camry® stature meter. directions and explanations on the meaning of each question. We collected and reviewed questionnaire sheets after they were completely filled. The completed questionnaires were adjusted for age and social, and school functions) were tabulated. Children with significantly poor quality of life were referred to a child psychologist.
In this study, quality of life assessment was questionnaire includes parallel child self-reports (age items ask how much of a problem a particular issue has been for patients during a certain period. Item responses are measured on a five-point rating scale, items on physical function, 5 items on emotional function, 5 items on social function, and 5 items on school function, yielding a total score. Each scale indicating higher quality of life.
This study was approved by the Medical Ethics to compare differences in quality of life between the
Results
Thalassemic children and their normal siblings were recruited to this study. There were 136 children, study because 4 children were below 5 years of age, 5 had mental retardation, and 7 children had no control group.
both groups was normal and the most common level of education level was high school with self-owned business as their main profession. (Table 1 ) Table 2 shows the hematologic profile of the thalassemic children. This profile was consistent with the thalassemia condition. We found the most of subjects it was unknown which parents were of subjects every month, most commonly with 3 bags Table 3 shows there were significant differences of quality of life between thalassemic children and their normal siblings. Assessments of the four quality of life domains in the thalassemic vs control groups showed the following: physical function 53.1 vs 71.5 parameter (Figure 1 ).
Discussion
We compared the quality of life of thalassemic children to their normal siblings, as representative family members to assess the effects of the disease and its treatment. The assessment of quality of life in children, especially in those with chronic diseases such as thalassemia is important. The negative impact of the disease and its treatment can affect the quality of life of patients and their family members, hence the need to assess both groups. The thalassemia major, a condition typically inherited from two carrier parents. There was also a small number of other thalassemic children.
Thalassemia major can often be prevented by avoiding marriage of two carrier parents or by performing prenatal diagnoses in high risk mothers. 5, 15 producing a carrier who can pass on the disease if normal offspring (not thalassemic or carrier). 5, 16 received monthly transfusions, with various blood volumes transfused depending on hemoglobin level upon visiting the hospital. The most common amount the most common hemoglobin level upon hospital visit
In the management of thalassemia, regular red blood cell transfusions can reduce the complications of anemia and ineffective erythropoiesis, permit normal growth and development throughout childhood, and extend survival in thalassemic children. 1, 15, 17 The decision to initiate regular transfusions is generally based on the observation of a hemoglobin concentration less than 6 g/dL. 1, 15 nutritional status, which is not in keeping with the theory that children with thalassemia have growth problem. This was caused by the anthropometry data showed abnormal condition (short stature) which in turn resulting in normal nutritional status.
Children with thalassemia are known to have abnormal growth. The etiology of these co-morbidities is typically ascribed to the toxic effect of regular blood transfusions related to iron overload. Malnutrition is primarily caused by inadequate nutrient intake, as indicated by the capacity to gain weight appropriately when provided with nutritional support in the absence of intestinal malabsorption. iron chelating therapy regularly after blood transfusions, with serum ferritin examinations every 3 months. We subjects had not received chelating therapy because not been checked yet. ineffective erythropoiesis, increased gastrointestinal absorption of iron and above all, multiple blood transfusions.
will circulate in the body, but the body cannot excrete more than 1 mg of iron per day.
The accumulation of iron results in progressive dysfunction of the heart, liver and endocrine glands.
Iron chelating agents are needed to control iron levels in patients who receive regular blood transfusions. considered the treatment of choice for patients with chronic iron overload due to blood transfusion. The time to start the iron chelating agents is levels, as well as the total iron binding capacity after regular transfusions.
Chelating therapy is typically
We assessed the quality of life of thalassemic module in a sample of healthy children and children with thalassemia.
generally two types of tools that can be used, generic measures and disease-specific measures. Each has its own advantages and disadvantages. Generic measure tools can be used in healthy or sick children with various diseases. Hence, they can be used to compare the quality of life of children with chronic illness to healthy children or children with other types of diseases. The disadvantage of these tools is that they cannot be used to assess specific symptoms of certain illnesses or possible side effects. On the other hand, specific measure tools cannot be used to compare sick children to healthy ones, but they are more sensitive and specific for certain symptoms or side effects of the disease. The choice of the tools depends on the subjects, specific conditions or the illness. 14 The reliability and validity of the tool also determines the validity of the assessment. For practical purposes, the ideal tool must be brief, but retain good reliability and validity, provide useful information, able to be filled by children of various ages and their parents, and be available both in generic and specific measures. assessment because it fulfills several criteria for such a valid tool. It has high validity and reliability (has been proven in several studies in children with malignancies, diabetes and heart disease), is available in generic and for cancer, asthma, diabetes, rheumatic heart disease, cerebral palsy, epilepsy and thalassemia), can be filled by children (self-report) or parents/guardians (proxy report), has been translated to several languages to facilitate usage, and is available for various age groups:
He has developed and made several modifications since of life of children with chronic illness may be compared to healthy/normal children as a control.
The results of our study are comparable to a previous study where the quality of life of thalassemic children was significantly lower than the control group. Our study also showed the results of each domain in the quality of life assessment: physical, previous study, school domain had the lowest mean have been limited, but needed. A study in Malaysia quality of life of thalassemic children compared to normal children as a control. These study reported that the quality of life of thalassemic children was significantly lower comparared to control group. Effects of thalassemia on quality of life included physical, social, emotional and school issues. A study in Malaysia reported that school function was the parameter most affected. Thalassemic children are frequently absent from school, since they routinely go to the hospital for blood transfusions and iron chelating therapy.
Indonesia used to assess quality of life in children with chronic illness, in particular, thalassemia. Our findings supported other studies in Malaysia and Thailand in that it also showed that children with thalassemia have a poorer quality of life. However, we were unable to evaluate if there was any improvement to quality of life after intervention, such as education for parents and consultations with child psychologists. Further study is needed in this area.
In conclusion, we found that thalassemic children had a lower quality of life compared to their clinically normal siblings, with school function the most negatively affected. 
